Natural Cycle Frozen Embryo Transfer (FET) Protocol
I must note that the provided evidence focuses primarily on embryo transfer numbers and outcomes rather than detailed natural cycle FET protocols. However, I can outline the protocol based on the available research evidence.
Protocol Overview
Natural cycle FET involves monitoring the patient's spontaneous ovulation and timing embryo transfer to coincide with the appropriate luteal phase, without exogenous hormonal stimulation for endometrial preparation.
Monitoring Phase
Cycle Day 2-3 Baseline
- Begin monitoring during early follicular phase
- Baseline ultrasound to assess endometrial thickness and rule out ovarian cysts
- Baseline hormonal assessment (estradiol, progesterone, LH)
Mid-Follicular Phase Monitoring
- Serial transvaginal ultrasounds every 2-3 days starting around cycle day 8-10
- Monitor dominant follicle growth (target: ≥16-18mm mean diameter)
- Monitor endometrial thickness (target: ≥7mm) 1
- Serial hormonal monitoring: estradiol, progesterone, and LH levels 2
- Natural cycle FET requires an average of 4.05 ± 1.39 clinic visits with multiple blood samplings 2
Ovulation Detection and Timing
Two Main Approaches:
1. Spontaneous Ovulation Detection (True Natural Cycle)
- Monitor for spontaneous LH surge via daily or twice-daily urine LH testing once follicle reaches 16-18mm
- Confirm LH surge with serum LH measurement
- No ovulation trigger administered 2
- No luteal phase support traditionally used 3
2. Modified Natural Cycle with Trigger
- Administer subcutaneous hCG injection (typically 5,000-10,000 IU) when dominant follicle reaches 18-20mm to trigger ovulation 2
- Reduces monitoring requirements to 3.03 ± 1.16 visits compared to true natural cycle 2
- Provides more scheduling flexibility 2
Embryo Transfer Timing
For Day 3 (Cleavage Stage) Embryos:
- Transfer 3 days after spontaneous LH surge or ovulation trigger
- Transfer 4 days after LH surge if using 48-hour cleavage embryos 4
For Day 5/6 (Blastocyst Stage) Embryos:
- Transfer 5-6 days after spontaneous LH surge or ovulation trigger
- Single embryo transfer (eSET) is strongly recommended for all blastocyst transfers regardless of quality or patient prognosis 5
Luteal Phase Support Options
Traditional Approach:
- No luteal phase support in true natural cycles 3
Modified Luteal Support (Emerging Evidence):
- Vaginal progesterone supplementation starting 48 hours before embryo transfer 6
- Modified protocol with additional support: recombinant hCG injection on day of transfer plus GnRH-agonist injection 4 days later showed significantly higher implantation (31%), clinical pregnancy (51%), and ongoing pregnancy rates (46%) compared to natural cycle without support (17%, 26%, 20% respectively) 4
Natural Proliferative Phase (NPP) Protocol Alternative:
- Initiate vaginal progesterone during proliferative phase once endometrium reaches ≥7mm thickness
- Start progesterone regardless of follicle size, as long as ovulation hasn't occurred 1
- This approach showed 49.1% live birth rate compared to 38.4% with artificial cycles 1
Protocol Selection Considerations
Modified Natural Cycle Advantages:
- Reduces monitoring burden and clinic visits 2
- More practical for scheduling 2
- Modified natural cycle with luteal support showed 40.6% clinical pregnancy rate and 36.3% live birth rate, significantly higher than artificial cycles (32.0% and 26.6%) 3
Common Pitfall:
- In modified natural cycles with planned trigger, >30% of patients may experience spontaneous LH surge before trigger can be administered, requiring protocol adjustment 2
- This necessitates close monitoring and flexibility in scheduling
Cycle Cancellation Criteria
- Absence of follicular development requiring switch to hormonal replacement protocol 2
- Premature ovulation before transfer can be scheduled
- Inadequate endometrial development (<7mm)
- Elevated progesterone levels before ovulation indicating premature luteinization
Number of Embryos to Transfer
Regardless of natural cycle protocol used, single embryo transfer (eSET) should be the standard when blastocysts are available 5. This recommendation prioritizes maternal and neonatal safety, as multiple embryo transfer significantly increases risks of: